| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Neoplasms Benign, Malignant and Unspecified : Posters : Topoiscmerase Inhibitors : Pharmacogenomic and Pharmacokinetic Assessment of Liposome Encapsulated SN-38 (LE-SN38) in Advanced Cancer Patients | published Wed, Nov 7, 2007 - 10:31 EST |
Presented at the 2004 ASCO Annual Meeting, New Orleans, LA
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Neoplasms Benign, Malignant and Unspecified : Posters : Topoiscmerase Inhibitors : Pharmacogenomic and Pharmacokinetic Assessment of Liposome Encapsulated SN-38 (LE-SN38) in Advanced Cancer Patients | published Wed, Nov 7, 2007 - 10:31 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |